These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 19273826)

  • 21. Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial.
    Logallo N; Novotny V; Assmus J; Kvistad CE; Alteheld L; Rønning OM; Thommessen B; Amthor KF; Ihle-Hansen H; Kurz M; Tobro H; Kaur K; Stankiewicz M; Carlsson M; Morsund Å; Idicula T; Aamodt AH; Lund C; Næss H; Waje-Andreassen U; Thomassen L
    Lancet Neurol; 2017 Oct; 16(10):781-788. PubMed ID: 28780236
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tenecteplase versus alteplase for stroke thrombolysis evaluation (TASTE): A multicentre, prospective, randomized, open-label, blinded-endpoint, controlled phase III non-inferiority trial protocol.
    Bivard A; Garcia-Esperon C; Churilov L; Spratt N; Russell M; Campbell BC; Choi P; Kleinig T; Ma H; Markus H; Molina C; Hsu C; Tsai CH; Meretoja A; Strbian D; Butcher K; Wu T; Davis S; Donnan G; Levi C; Parsons M
    Int J Stroke; 2023 Jul; 18(6):751-756. PubMed ID: 36655938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tenecteplase vs Alteplase Before Endovascular Therapy in Basilar Artery Occlusion.
    Alemseged F; Ng FC; Williams C; Puetz V; Boulouis G; Kleinig TJ; Rocco A; Wu TY; Shah D; Arba F; Kaiser D; Di Giuliano F; Morotti A; Sallustio F; Dewey HM; Bailey P; O'Brien B; Sharma G; Bush S; Dowling R; Diomedi M; Churilov L; Yan B; Parsons MW; Davis SM; Mitchell PJ; Yassi N; Campbell BCV;
    Neurology; 2021 Mar; 96(9):e1272-e1277. PubMed ID: 33408145
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of alteplase 3 to 6 hours after stroke in the EPITHET-DEFUSE combined dataset: post hoc case-control study.
    Ogata T; Christensen S; Nagakane Y; Ma H; Campbell BC; Churilov L; Lansberg MG; Straka M; De Silva DA; Mlynash M; Bammer R; Olivot JM; Desmond PM; Albers GW; Davis SM; Donnan GA;
    Stroke; 2013 Jan; 44(1):87-93. PubMed ID: 23250996
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction of Early Arterial Recanalization and Tissue Fate in the Selection of Patients With the Greatest Potential to Benefit From Intravenous Tissue-Type Plasminogen Activator.
    Leiva-Salinas C; Patrie JT; Xin W; Michel P; Jovin T; Wintermark M
    Stroke; 2016 Feb; 47(2):397-403. PubMed ID: 26696647
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Residual vessel length on magnetic resonance angiography identifies poor responders to alteplase in acute middle cerebral artery occlusion patients: exploratory analysis of the Japan Alteplase Clinical Trial II.
    Hirano T; Sasaki M; Mori E; Minematsu K; Nakagawara J; Yamaguchi T;
    Stroke; 2010 Dec; 41(12):2828-33. PubMed ID: 21030700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tenecteplase for the treatment of acute ischemic stroke: A review of completed and ongoing randomized controlled trials.
    Coutts SB; Berge E; Campbell BC; Muir KW; Parsons MW
    Int J Stroke; 2018 Dec; 13(9):885-892. PubMed ID: 30035698
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Femoral Access-Site Complications with Tenecteplase versus Alteplase before Mechanical Thrombectomy for Large-Vessel-Occlusion Stroke.
    Hendrix P; Collins MK; Goren O; Weiner GM; Dalal SS; Melamed I; Kole MJ; Griessenauer CJ; Noto A; Schirmer CM
    AJNR Am J Neuroradiol; 2023 Jun; 44(6):681-686. PubMed ID: 37169538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tenecteplase Thrombolysis for Acute Ischemic Stroke.
    Warach SJ; Dula AN; Milling TJ
    Stroke; 2020 Nov; 51(11):3440-3451. PubMed ID: 33045929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tenecteplase versus alteplase for large vessel occlusion recanalization (T-FLAVOR): Trial protocol.
    Kawano H; Hirano T; Inoue M; Fukuda-Doi M; Iwasaki K; Omae K; Tanaka K; Yamamoto H; Koga M; Sakai N; Nagao T; Sasaki M; Hayakawa N; Toyoda K
    Eur Stroke J; 2022 Mar; 7(1):71-75. PubMed ID: 35300254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Different doses of tenecteplase vs alteplase in thrombolysis therapy of acute ischemic stroke: evidence from randomized controlled trials.
    Xu N; Chen Z; Zhao C; Xue T; Wu X; Sun X; Wang Z
    Drug Des Devel Ther; 2018; 12():2071-2084. PubMed ID: 30013325
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of Time to Thrombolysis With Early Reperfusion After Alteplase and Tenecteplase in Patients With Large Vessel Occlusion.
    Yogendrakumar V; Beharry J; Churilov L; Pesavento L; Alidin K; Ugalde M; Weir L; Mitchell PJ; Kleinig TJ; Yassi N; Thijs VN; Wu TY; Brown H; Dewey HM; Wijeratne T; Yan B; Sharma GJ; Desmond P; Parsons MW; Donnan GA; Davis SM; Campbell BCV;
    Neurology; 2024 Apr; 102(7):e209166. PubMed ID: 38502892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel thrombolytic drugs: will they make a difference in the treatment of ischaemic stroke?
    Meretoja A; Tatlisumak T
    CNS Drugs; 2008; 22(8):619-29. PubMed ID: 18601301
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tenecteplase versus alteplase after acute ischemic stroke at high age.
    Thommessen B; Næss H; Logallo N; Kvistad CE; Waje-Andreassen U; Ihle-Hansen H; Ihle-Hansen H; Thomassen L; Morten Rønning O
    Int J Stroke; 2021 Apr; 16(3):295-299. PubMed ID: 32631157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tenecteplase versus Alteplase for Stroke Thrombolysis Evaluation Trial in the Ambulance (Mobile Stroke Unit-TASTE-A): protocol for a prospective randomised, open-label, blinded endpoint, phase II superiority trial of tenecteplase versus alteplase for ischaemic stroke patients presenting within 4.5 hours of symptom onset to the mobile stroke unit.
    Bivard A; Zhao H; Coote S; Campbell B; Churilov L; Yassi N; Yan B; Valente M; Sharobeam A; Balabanski A; Dos Santos A; Ng F; Langenberg F; Stephenson M; Smith K; Bernard S; Thijs V; Cloud G; Choi P; Ma H; Wijeratne T; Chen C; Olenko L; Davis SM; Donnan GA; Parsons M
    BMJ Open; 2022 Apr; 12(4):e056573. PubMed ID: 35487712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tenecteplase versus alteplase before endovascular thrombectomy (EXTEND-IA TNK): A multicenter, randomized, controlled study.
    Campbell BC; Mitchell PJ; Churilov L; Yassi N; Kleinig TJ; Yan B; Dowling RJ; Bush SJ; Dewey HM; Thijs V; Simpson M; Brooks M; Asadi H; Wu TY; Shah DG; Wijeratne T; Ang T; Miteff F; Levi C; Krause M; Harrington TJ; Faulder KC; Steinfort BS; Bailey P; Rice H; de Villiers L; Scroop R; Collecutt W; Wong AA; Coulthard A; Barber PA; McGuinness B; Field D; Ma H; Chong W; Chandra RV; Bladin CF; Brown H; Redmond K; Leggett D; Cloud G; Madan A; Mahant N; O'Brien B; Worthington J; Parker G; Desmond PM; Parsons MW; Donnan GA; Davis SM;
    Int J Stroke; 2018 Apr; 13(3):328-334. PubMed ID: 28952914
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial.
    Menon BK; Buck BH; Singh N; Deschaintre Y; Almekhlafi MA; Coutts SB; Thirunavukkarasu S; Khosravani H; Appireddy R; Moreau F; Gubitz G; Tkach A; Catanese L; Dowlatshahi D; Medvedev G; Mandzia J; Pikula A; Shankar J; Williams H; Field TS; Manosalva A; Siddiqui M; Zafar A; Imoukhuede O; Hunter G; Demchuk AM; Mishra S; Gioia LC; Jalini S; Cayer C; Phillips S; Elamin E; Shoamanesh A; Subramaniam S; Kate M; Jacquin G; Camden MC; Benali F; Alhabli I; Bala F; Horn M; Stotts G; Hill MD; Gladstone DJ; Poppe A; Sehgal A; Zhang Q; Lethebe BC; Doram C; Ademola A; Shamy M; Kenney C; Sajobi TT; Swartz RH;
    Lancet; 2022 Jul; 400(10347):161-169. PubMed ID: 35779553
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tenecteplase Versus Alteplase Between 3 and 4.5 Hours in Low National Institutes of Health Stroke Scale.
    Rønning OM; Logallo N; Thommessen B; Tobro H; Novotny V; Kvistad CE; Aamodt AH; Næss H; Waje-Andreassen U; Thomassen L
    Stroke; 2019 Feb; 50(2):498-500. PubMed ID: 30602354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Norwegian tenecteplase stroke trial (NOR-TEST): randomised controlled trial of tenecteplase vs. alteplase in acute ischaemic stroke.
    Logallo N; Kvistad CE; Nacu A; Naess H; Waje-Andreassen U; Asmuss J; Aamodt AH; Lund C; Kurz MW; Rønning OM; Salvesen R; Idicula TT; Thomassen L
    BMC Neurol; 2014 May; 14():106. PubMed ID: 24886064
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.